Impact of Tumour RAS/BRAF Status in a First-Line Study of Panitumumab + FOLFIRI in Patients With Metastatic Colorectal Cancer
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2016.343
Full Text
Open PDFAbstract
Available in full text
Date
October 20, 2016
Authors
Publisher
Springer Science and Business Media LLC